Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease arthritis
Phenotype C0021400|influenza
Sentences 10
PubMedID- 22999900 influenza h1n1 infection in a patient with rheumatoid arthritis treated with tocilizumab.
PubMedID- 26343963 Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis b vaccines among persons 15–59 years of age.
PubMedID- 22887851 Objectives: we assessed the influence of tocilizumab (tcz), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following influenza vaccination in patients with rheumatoid arthritis (ra).
PubMedID- 19246078 The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.
PubMedID- 21763385 Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis b vaccines among persons 15-59 years of age.
PubMedID- 22577464 The observation of humoral responses after influenza vaccination in patients with rheumatoid arthritis treated with japanese oriental (kampo) medicine: an observational study.
PubMedID- 26425339 Extracellular il-33 has also been detected in human blood and synovial fluids in pathological conditions [31], where cells have been damaged (during rheumatoid arthritis or infection with influenza virus, respectively) and in mouse peritoneal and bronchoalveolar lavage fluid [32].
PubMedID- 20148144 This report represents the first detailed description of a possible post-infectious arthritis following infection with an influenza virus.
PubMedID- 20204666 influenza h1n1 infection in a patient with psoriatic arthritis in treatment with adalimumab: a case report.
PubMedID- 24445384 The objective of this observational study is to determine characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis (ra).

Page: 1